Article Information
History
- December 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chengzi I. Kaku1,3,
- Elizabeth R. Champney1,
- Johan Normark2,
- Carl E. Johnson1,
- Clas Ahlm2,
- Mrunal Sakharkar1,
- Margaret E. Ackerman3,4,
- Mattias N. E. Forsell2 and
- Laura M. Walker1,5,*
- 1Adimab LLC, Lebanon, NH 03766, USA
- 2Division of Immunology, Department of Clinical Microbiology, Umeå University, Umeå, Sweden
- 3Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA
- 4Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA
- 5Adagio Therapeutics, Inc., Waltham, MA 02451, USA
- ↵*Corresponding author. E-mail: laura.walker{at}adimab.com (L.M.W.)